Charles Schwab’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $644K | Buy |
294,106
+277,868
| +1,711% | +$609K | ﹤0.01% | 3042 |
|
|
2025
Q1 | $17.5K | Hold |
16,238
| – | – | ﹤0.01% | 3467 |
|
|
2024
Q4 | $16.9K | Hold |
16,238
| – | – | ﹤0.01% | 3489 |
|
|
2024
Q3 | $20.3K | Hold |
16,238
| – | – | ﹤0.01% | 3484 |
|
|
2024
Q2 | $19.3K | Hold |
16,238
| – | – | ﹤0.01% | 3591 |
|
|
2024
Q1 | $16.4K | Hold |
16,238
| – | – | ﹤0.01% | 3441 |
|
|
2023
Q4 | $17.2K | Hold |
16,238
| – | – | ﹤0.01% | 3497 |
|
|
2023
Q3 | $26.6K | Hold |
16,238
| – | – | ﹤0.01% | 3481 |
|
|
2023
Q2 | $25.5K | Hold |
16,238
| – | – | ﹤0.01% | 3525 |
|
|
2023
Q1 | $23.2K | Hold |
16,238
| – | – | ﹤0.01% | 3488 |
|
|
2022
Q4 | $38.3K | Hold |
16,238
| – | – | ﹤0.01% | 3411 |
|
|
2022
Q3 | $33K | Buy |
+16,238
| New | +$33K | ﹤0.01% | 3413 |
|
|
2017
Q2 | – | Sell |
-9
| Closed | -$9K | – | 3131 |
|
|
2017
Q1 | $9K | Hold |
9
| – | – | ﹤0.01% | 3054 |
|
|
2016
Q4 | $26K | Buy |
+9
| New | +$26K | ﹤0.01% | 3071 |
|